Moderna's $1 Billion Revenue Forecast Cut Sends Stock

Moderna's $1 Billion Revenue Forecast Cut Sends Stock

2 weeks from now

Jan 13, 2025  · Moderna shares tumbled Monday after the company cut its 2025 revenue forecast by $1 billion. The company expects much of its revenue to be realized in the back half of the year from its Covid-19 ...

investopedia.com

Moderna Cuts 2025 Revenue Forecast By $1 Billion, Shares Drop …

2 weeks from now

Jan 14, 2025  · Moderna shares tumbled nearly 17% on Monday after the drugmaker slashed its 2025 revenue forecast by $1 billion and announced plans to cut $1.5 billion in expenses this year. The company faces ...

msn.com

Moderna Stock Plummets After $1 Billion Cut To 2025 Sales Forecast

2 weeks from now

Jan 13, 2025  · Moderna (MRNA) shares plummeted $9.29, or 22%, to $22.96 in early trading after the company slashed its 2025 sales forecast, sparking investor concerns. The revised …

wallstreetpit.com

Moderna Stock Plunges 20% After Company Lowers 2025 Sales …

2 weeks from now

Jan 13, 2025  · Moderna on Monday lowered its 2025 sales guidance by roughly $1 billion due to a few potential headwinds later this year, as the biotech company continues to cut costs and …

cashreview.com

Moderna Cuts Sales Forecast On Weaker Vaccine Demand - Yahoo …

2 weeks from now

Jan 13, 2025  · The company now expects $1.5 billion to $2 billion in revenue for 2025. Moderna's stock slid more than 20% in early trading Monday on the news to $33.05 per share — a fraction of its COVID highs ...

yahoo.com

Moderna Stock Heads For Worst Day Ever On Forecast Cut

2 weeks from now

Jan 13, 2025  · Moderna (MRNA) stock is plummeting, after the biotech giant slashed its 2025 revenue forecast. ... lowered its 2025 revenue forecast to a range of $1.5 billion to $2.5 billion, …

schaeffersresearch.com

Watch These Moderna Price Levels As Stock Plummets After

2 weeks from now

Jan 14, 2025  · Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its 2025 revenue forecast by $1 billion. The stock broke …

investopedia.com

Moderna Shares Plunge After Predicting Steep 2025 Sales Decline

2 weeks from now

Jan 13, 2025  · The company revised its 2025 revenue expectations to a range of $1.5 billion to $2.5 billion, falling far short of Wall Street's consensus of $2.92 billion, according to the …

newsweek.com

Moderna Shares Drop To Five-Year Low After Slashing Revenue, …

2 weeks from now

Jan 13, 2025  · Moderna, which makes the Spikevax RNA-based Covid-19 vaccine, said before the bell it now expects between $1.5 billion and $2.5 billion in revenue in 2025, down from a …

marketwatch.com

Moderna Provides Business And Pipeline Updates At 43rd Annual …

2 weeks from now

Jan 13, 2025  · Achieved 2024 product sales of $3.0 to 3.1 billion (unaudited) and an ending cash balance of approximately $9.5 billion (unaudited) Updates 2025 expected revenue range to …

modernatx.com

Moderna Slashes Sales Forecast By $1B, Eyes FDA Approval To …

2 weeks from now

The company now expects annual revenue between $1.5 billion and $2.5 billion, primarily in the latter half of the year. That's down from its earlier estimate of $2.5 billion to $3.5 billion and ...

yahoo.com

Moderna Lowers Full-Year Revenue Outlook, Plans To Cut Cash …

2 weeks from now

Moderna (MRNA) shares fell intraday Monday after the company cut its full-year revenue outlook while the drugmaker aims to reduce cash costs by $1 billion in 2025 amid its ongoing cost …

msn.com

What Led To Moderna’s 20% Stock Drop? Here’s The Full Story

2 weeks from now

Jan 13, 2025  · Moderna's stock fell 20% on January 8, 2025, after the company revised its 2025 sales forecast downward by approximately $1 billion amid several potential ... Moderna’s stock …

dataconomy.com

StockWatch: Moderna's $1.1B R&D Cut, Profitability Delay Jolt …

2 weeks from now

Sep 16, 2024  · During R&D Day, Moderna cut the low end of its revenue forecast by $500 million, resulting in a range of between $2.5 billion to $3.5 billion—before quickly adding that it …

genengnews.com

Moderna Cuts 2025 Sales Forecast By $1 Billion On Weak Vaccine …

2 weeks from now

Jan 13, 2025  · The company expects $1.5 billion to $2.5 billion in annual revenue, mostly in the second half, which is lower than a prior forecast of $2.5 billion to $3.5 billion and below market …

marketscreener.com

Moderna Issues Outlook For FY25 And Beyond, Cuts R&D Budget; …

2 weeks from now

Sep 12, 2024  · Moderna noted that it is implementing portfolio prioritization and cost efficiencies to reduce R&D expense by $1.1 billion, to $3.6 billion to $3.8 billion in 2027 from $4.8 billion in …

businessinsider.com

Moderna: The Good News Isn't Enough - Seeking Alpha

2 weeks from now

4 days ago  · Keep in mind that Moderna's cash pile is currently $7 billion, plus ~$2 billion in non-current investments, which the company uses in the calculation to claim ~$9 billion.

seekingalpha.com

Moderna (MRNA) Expected To Beat Earnings Estimates: What To

2 weeks from now

12 hours ago  · This quarter's revenue is expected to be $570.11 million, up 29.7% from the year-ago quarter. Over the last 30 days, the consensus EPS estimate for Alnylam has been revised …

nasdaq.com

Stock Market Today: Dow, S&P 500, Nasdaq Recover As Traders …

2 weeks from now

4 days ago  · Snap shares soared as much as 15% in after-hours trading on Tuesday after the company beat on both the top and bottom lines and guided to first quarter revenue that was …

yahoo.com

GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion …

2 weeks from now

2 days ago  · Wednesday, GSK Plc (NYSE:GSK) reported fourth-quarter sales of $10.40 billion (8.12 billion Sterling Pounds), up 1% year-over-year and up 4% on constant currency. The …

yahoo.com